SCHEMBL19976762

SCHEMBL19976762

CC1(CN/C(=N/C(=O)c2ccc(F)c(F)c2)Nc2n[nH]c3ccc(C(F)(F)F)cc23)COC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 2/20 0.40
GSK3B P49841 2/20 0.39
MAPK1 P28482 1/20 0.38
MAPKAPK3 Q16644 1/20 0.38
MAPK6 Q16659 1/20 0.38
TRPA1 O75762 2/20 0.38
MAPK8 P45983 2/20 0.37
MAPK10 P53779 2/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CRHR1 P34998 3/20 0.35
FADS1 O60427 1/20 0.35
CCR2 P41597 4/20 0.35
KCNH2 Q12809 4/20 0.35
NTRK1 P04629 2/20 0.35
AURKA O14965 1/20 0.35
INSR P06213 1/20 0.35
IGF1R P08069 1/20 0.35
AURKB Q96GD4 1/20 0.35
ALK Q9UM73 1/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976734 0.88 MAPK10 (0.36) GSK3BMAPK1MAPK8MAPK10HDAC6
SCHEMBL19976800 0.84 GSK3B (0.43) MAP2K4GSK3BMAPK1MAPKAPK3MAPK6
SCHEMBL19976854 0.84 GSK3B (0.42) MAP2K4GSK3BMAPK1MAPKAPK3MAPK6
SCHEMBL19976736 0.82 MAP2K4 (0.44) MAP2K4GSK3BMAPK1MAPKAPK3MAPK6
SCHEMBL19976815 0.81 GSK3B (0.44) MAP2K4GSK3BMAPK1MAPKAPK3MAPK6
SCHEMBL19976888 0.77 GSK3B (0.51) MAP2K4GSK3BMAPK1MAPK6TRPA1
SCHEMBL19976767 0.77 GSK3B (0.51) MAP2K4GSK3BMAPK1MAPK6TRPA1
SCHEMBL19976812 0.75 GSK3B (0.51) MAP2K4GSK3BMAPK1MAPK6TRPA1
SCHEMBL18558609 0.75 HDAC3 (0.38) HDAC6NTRK1MAPT
SCHEMBL19976725 0.75 GSK3B (0.52) MAP2K4GSK3BMAPK1MAPKAPK3MAPK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed